{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:28:19Z","timestamp":1793658499840,"version":"4.5.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Protein ubiquitylation is involved in a plethora of cellular processes. While antibodies directed at ubiquitin remnants (K-\u025b-GG) have improved the ability to monitor ubiquitylation using mass spectrometry, methods for highly\u00a0multiplexed measurement of ubiquitylation in tissues and primary cells using sub-milligram amounts of sample remains a challenge. Here, we present a highly sensitive, rapid and multiplexed protocol termed UbiFast for quantifying ~10,000 ubiquitylation sites from as little as 500\u2009\u03bcg peptide per sample from cells or tissue in a TMT10plex in ca. 5\u2009h. High-field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS) is used to improve quantitative accuracy for posttranslational modification analysis. We use the approach to rediscover substrates of the E3 ligase targeting drug lenalidomide and to identify proteins modulated by ubiquitylation in models of basal and luminal human breast cancer. The sensitivity and speed of the UbiFast method makes it suitable for large-scale studies in primary tissue samples.<\/jats:p>","DOI":"10.1038\/s41467-019-14175-1","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T06:03:05Z","timestamp":1579240985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["Rapid and deep-scale ubiquitylation profiling for biology and translational research"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5312-1402","authenticated-orcid":false,"given":"Namrata D.","family":"Udeshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak C.","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6040-4854","authenticated-orcid":false,"given":"Shankha","family":"Satpathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaunt","family":"Fereshetian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Gasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Svinkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan E.","family":"Olive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0197-5451","authenticated-orcid":false,"given":"Benjamin L.","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2245-528X","authenticated-orcid":false,"given":"Philipp","family":"Mertins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7203-4299","authenticated-orcid":false,"given":"Steven A.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"key":"14175_CR1","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrm.2016.91","volume":"17","author":"L Buetow","year":"2016","unstructured":"Buetow, L. & Huang, D. T. Structural insights into the catalysis and regulation of E3 ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 17, 626\u2013642 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"14175_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrm3173","volume":"12","author":"AM Weissman","year":"2011","unstructured":"Weissman, A. M., Shabek, N. & Ciechanover, A. The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation. Nat. Rev. Mol. Cell Biol. 12, 605\u2013620 (2011).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"14175_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1042\/BST20150209","volume":"44","author":"VK Chaugule","year":"2016","unstructured":"Chaugule, V. K. & Walden, H. Specificity and disease in the ubiquitin system. Biochem. Soc. Trans. 44, 212\u2013227 (2016).","journal-title":"Biochem. Soc. Trans."},{"key":"14175_CR4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nature07960","volume":"458","author":"D Hoeller","year":"2009","unstructured":"Hoeller, D. & Dikic, I. Targeting the ubiquitin system in cancer therapy. Nature 458, 438\u2013444 (2009).","journal-title":"Nature"},{"key":"14175_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.gde.2010.10.004","volume":"21","author":"V Kirkin","year":"2011","unstructured":"Kirkin, V. & Dikic, I. Ubiquitin networks in cancer. Curr. Opin. Genet. Dev. 21, 21\u201328 (2011).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"14175_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1244851","volume":"343","author":"J Kronke","year":"2014","unstructured":"Kronke, J. et al. Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science 343, 301\u2013305 (2014).","journal-title":"Science"},{"key":"14175_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrc3120","volume":"11","author":"S Lipkowitz","year":"2011","unstructured":"Lipkowitz, S. & Weissman, A. M. RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat. Rev. Cancer 11, 629\u2013643 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"14175_CR8","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/nm.4372","volume":"23","author":"H Janouskova","year":"2017","unstructured":"Janouskova, H. et al. Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors. Nat. Med. 23, 1046\u20131054 (2017).","journal-title":"Nat. Med."},{"key":"14175_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nchembio.2355","volume":"13","author":"MJ Walczak","year":"2017","unstructured":"Walczak, M. J., Petzold, G. & Thoma, N. H. Targeted protein degradation: you can glue it too! Nat. Chem. Biol. 13, 452\u2013453 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"14175_CR10","doi-asserted-by":"crossref","unstructured":"Kim, W. et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 44, 325\u2013340 (2011).","DOI":"10.1016\/j.molcel.2011.08.025"},{"key":"14175_CR11","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1038\/nprot.2013.120","volume":"8","author":"ND Udeshi","year":"2013","unstructured":"Udeshi, N. D., Mertins, P., Svinkina, T. & Carr, S. A. Large-scale identification of ubiquitination sites by mass spectrometry. Nat. Protoc. 8, 1950 (2013).","journal-title":"Nat. Protoc."},{"key":"14175_CR12","doi-asserted-by":"publisher","first-page":"4722","DOI":"10.1021\/pr300536k","volume":"11","author":"CH Na","year":"2012","unstructured":"Na, C. H. et al. Synaptic protein ubiquitination in rat brain revealed by antibody-based ubiquitome analysis. J. Proteome Res. 11, 4722\u20134732 (2012).","journal-title":"J. Proteome Res."},{"key":"14175_CR13","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nbt.1654","volume":"28","author":"G Xu","year":"2010","unstructured":"Xu, G., Paige, J. S. & Jaffrey, S. R. Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling. Nat. Biotechnol. 28, 868\u2013873 (2010).","journal-title":"Nat. Biotechnol."},{"key":"14175_CR14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.15252\/msb.20145880","volume":"11","author":"S Satpathy","year":"2015","unstructured":"Satpathy, S. et al. Systems-wide analysis of BCR signalosomes and downstream phosphorylation and ubiquitylation. Mol. Syst. Biol. 11, 810 (2015).","journal-title":"Mol. Syst. Biol."},{"key":"14175_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/nature12043","author":"SA Sarraf","year":"2013","unstructured":"Sarraf, S. A. et al. Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature https:\/\/doi.org\/10.1038\/nature12043 (2013).","journal-title":"Nature"},{"key":"14175_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cell.2011.09.019","volume":"147","author":"MJ Emanuele","year":"2011","unstructured":"Emanuele, M. J. et al. Global identification of modular Cullin-RING ligase substrates. Cell 147, 459\u2013474 (2011).","journal-title":"Cell"},{"key":"14175_CR17","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1074\/mcp.M116.058420","volume":"15","author":"JM Gendron","year":"2016","unstructured":"Gendron, J. M. et al. Using the ubiquitin-modified proteome to monitor distinct and spatially restricted protein homeostasis dysfunction. Mol. Cell Proteomics 15, 2576\u20132593 (2016).","journal-title":"Mol. Cell Proteomics"},{"key":"14175_CR18","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/ncb2579","volume":"14","author":"LK Povlsen","year":"2012","unstructured":"Povlsen, L. K. et al. Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. Nat. Cell Biol. 14, 1089\u20131098 (2012).","journal-title":"Nat. Cell Biol."},{"key":"14175_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.cels.2016.08.009","volume":"3","author":"CM Rose","year":"2016","unstructured":"Rose, C. M. et al. Highly multiplexed quantitative mass spectrometry analysis of ubiquitylomes. Cell Syst. 3, 395\u2013403 e394 (2016).","journal-title":"Cell Syst."},{"key":"14175_CR20","doi-asserted-by":"publisher","first-page":"9848","DOI":"10.1073\/pnas.87.24.9848","volume":"87","author":"D Suckau","year":"1990","unstructured":"Suckau, D. et al. Molecular epitope identification by limited proteolysis of an immobilized antigen-antibody complex and mass spectrometric peptide mapping. Proc. Natl Acad. Sci. USA 87, 9848\u20139852 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"14175_CR21","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/(SICI)1096-9888(200004)35:4<493::AID-JMS987>3.0.CO;2-I","volume":"35","author":"KM Downard","year":"2000","unstructured":"Downard, K. M. Contributions of mass spectrometry to structural immunology. J. Mass Spectrom. 35, 493\u2013503 (2000).","journal-title":"J. Mass Spectrom."},{"key":"14175_CR22","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nmeth.1714","volume":"8","author":"L Ting","year":"2011","unstructured":"Ting, L., Rad, R., Gygi, S. P. & Haas, W. MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics. Nat. Methods 8, 937\u2013940 (2011).","journal-title":"Nat. Methods"},{"key":"14175_CR23","doi-asserted-by":"publisher","first-page":"7150","DOI":"10.1021\/ac502040v","volume":"86","author":"GC McAlister","year":"2014","unstructured":"McAlister, G. C. et al. MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes. Anal. Chem. 86, 7150\u20137158 (2014).","journal-title":"Anal. Chem."},{"key":"14175_CR24","doi-asserted-by":"publisher","first-page":"9529","DOI":"10.1021\/acs.analchem.8b02233","volume":"90","author":"AS Hebert","year":"2018","unstructured":"Hebert, A. S. et al. Comprehensive single-shot proteomics with FAIMS on a hybrid orbitrap mass spectrometer. Anal. Chem. 90, 9529\u20139537 (2018).","journal-title":"Anal. Chem."},{"key":"14175_CR25","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.8b05399","author":"DK Schweppe","year":"2019","unstructured":"Schweppe, D. K. et al. Characterization and optimization of multiplexed quantitative analyses using high-field asymmetric-waveform ion mobility mass spectrometry. Anal. Chem. https:\/\/doi.org\/10.1021\/acs.analchem.8b05399 (2019).","journal-title":"Anal. Chem."},{"key":"14175_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03309-6","volume":"9","author":"A Hogrebe","year":"2018","unstructured":"Hogrebe, A. et al. Benchmarking common quantification strategies for large-scale phosphoproteomics. Nat. Commun. 9, 1045 (2018).","journal-title":"Nat. Commun."},{"key":"14175_CR27","first-page":"542","volume":"18","author":"SA Myers","year":"2019","unstructured":"Myers, S. A. et al. Evaluation of advanced precursor determination for Tandem Mass Tag (TMT)-based quantitative proteomics across instrument platforms. J. Proteome Res. 18, 542\u2013547 (2019).","journal-title":"J. Proteome Res."},{"key":"14175_CR28","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1021\/acs.jproteome.8b00016","volume":"17","author":"JD O\u2019Connell","year":"2018","unstructured":"O\u2019Connell, J. D., Paulo, J. A., O\u2019Brien, J. J. & Gygi, S. P. Proteome-wide evaluation of two common protein quantification methods. J. Proteome Res. 17, 1934\u20131942 (2018).","journal-title":"J. Proteome Res."},{"key":"14175_CR29","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.celrep.2013.08.022","volume":"4","author":"S Li","year":"2013","unstructured":"Li, S. et al. Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. Cell Rep. 4, 1116\u20131130 (2013).","journal-title":"Cell Rep."},{"key":"14175_CR30","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s41596-018-0006-9","volume":"13","author":"P Mertins","year":"2018","unstructured":"Mertins, P. et al. Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry. Nat. Protoc. 13, 1632\u20131661 (2018).","journal-title":"Nat. Protoc."},{"key":"14175_CR31","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1074\/mcp.TIR119.001385","volume":"18","author":"J Zecha","year":"2019","unstructured":"Zecha, J. et al. TMT labeling for the masses: a robust and cost-efficient, in-solution labeling approach. Mol. Cell Proteomics 18, 1468\u20131478 (2019).","journal-title":"Mol. Cell Proteomics"},{"key":"14175_CR32","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/cr.2016.40","volume":"26","author":"H Hu","year":"2016","unstructured":"Hu, H. & Sun, S. C. Ubiquitin signaling in immune responses. Cell Res. 26, 457\u2013483 (2016).","journal-title":"Cell Res."},{"key":"14175_CR33","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.15252\/embj.201694300","volume":"35","author":"SA Wagner","year":"2016","unstructured":"Wagner, S. A., Satpathy, S., Beli, P. & Choudhary, C. SPATA2 links CYLD to the TNF-alpha receptor signaling complex and modulates the receptor signaling outcomes. EMBO J. 35, 1868\u20131884 (2016).","journal-title":"EMBO J."},{"key":"14175_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1326-5","volume":"17","author":"A Marra","year":"2019","unstructured":"Marra, A., Viale, G. & Curigliano, G. Recent advances in triple negative breast cancer: the immunotherapy era. BMC Med. 17, 90 (2019).","journal-title":"BMC Med"},{"key":"14175_CR35","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1074\/mcp.O114.047555","volume":"14","author":"T Svinkina","year":"2015","unstructured":"Svinkina, T. et al. Deep, quantitative coverage of the lysine acetylome using novel anti-acetyl-lysine antibodies and an optimized proteomic workflow. Mol. Cell Proteomics 14, 2429\u20132440 (2015).","journal-title":"Mol. Cell Proteomics"},{"key":"14175_CR36","doi-asserted-by":"publisher","unstructured":"Donovan, K. A. et al. Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome. Elife https:\/\/doi.org\/10.7554\/eLife.38430 (2018).","DOI":"10.7554\/eLife.38430"},{"key":"14175_CR37","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1182\/blood-2018-05-852798","volume":"132","author":"EC Fink","year":"2018","unstructured":"Fink, E. C. et al. Crbn (I391V) is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice. Blood 132, 1535\u20131544 (2018).","journal-title":"Blood"},{"key":"14175_CR38","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nmeth.2518","volume":"10","author":"P Mertins","year":"2013","unstructured":"Mertins, P. et al. Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat. Methods 10, 634\u2013637 (2013).","journal-title":"Nat. Methods"},{"key":"14175_CR39","doi-asserted-by":"publisher","first-page":"7548","DOI":"10.1021\/acs.analchem.6b00946","volume":"88","author":"PJ Ippoliti","year":"2016","unstructured":"Ippoliti, P. J. et al. Automated microchromatography enables multiplexing of immunoaffinity enrichment of peptides to greater than 150 for targeted MS-based assays. Anal. Chem. 88, 7548\u20137555 (2016).","journal-title":"Anal. Chem."},{"key":"14175_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14864","volume":"8","author":"KL Huang","year":"2017","unstructured":"Huang, K. L. et al. Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat. Commun. 8, 14864 (2017).","journal-title":"Nat. Commun."},{"key":"14175_CR41","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"14175_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1\u201313 (2009).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14175-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14175-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14175-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T12:09:38Z","timestamp":1670242178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14175-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["14175"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-14175-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/785378","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,17]]},"assertion":[{"value":"14 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.L.E. has received research funding from Celgene and Deerfield. He has received consulting fees from GRAIL, and he serves on the scientific advisory boards for Skyhawk Therapeutics and Exo Therapeutics. S.A.C. has received research funding from Celgene. He has received consulting fees from Pfizer and Biogen, and he serves on the scientific advisory boards of Kymera, Seer and PTM BioLabs. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"359"}}